Pancreatoduodenectomy for Periampullary Tumors Presenting with Acute Pancreatitis

Table 1

Demographic characteristics for patients in the study group.

No.	a	b	c	d	e	f	g	h	i	j	k	l	m	n	o	p	q	r
1	M	44	395	8	①	①②③④	5.73	8.2	2.9	0.16	38.8	2.39	339.9	6.82	Y	Incline to intraductal papilloma of the pancreas	①	—
2	M	33	180	3	①	②③④	4.78	13.4	3.7	0.3	36.3	2.25	395.3	6.15	N	—	①	—
3	M	69	120	2	①	①③	7.88	7.8	2.3	0.15	29.8	2.17	437.1	17.82	Y	Chronic inflammation with fibrous tissue hyperplasia	①	—
4	F	58	60	1	②	①	8.46	10.6	3.5	0.11	24.1	2.08	440.2	56.26	Y	Adenocarcinoma	②	T3N1M0
5	M	32	150	3	①	①③	9.95	9.9	2.9	0.09	26.8	1.68	378.5	51.76	N	—	⑤	T3N0M0
6	F	43	210	3	②	①②③	6.84	26.2	7.8	0.08	26.7	2.01	400.2	33.83	N	—	①	—
7	F	50	60	1	③	①⑤	11.2	7.1	2.9	0.19	33.8	1.88	3127.7	17.20	N	—	①	—
8	M	51	120	2	①	①③	9.22	8.6	3.2	0.17	34.5	2.26	470.8	22.71	Y	Duodenal papillary adenoma	④	—
9	F	48	30	3	⑤	①③⑥	12.1	17.6	4.5	0.21	36.2	1.74	330.3	27.14	Y	Duodenal adenoma with high grade intraepithelial neoplasia	③	T3N1M0
10	M	49	20	4	④	①②③	10.05	29.2	7.6	0.16	34.4	2.18	379.9	129.33	Y	Adenocarcinoma	②	T3N0M0
11	M	65	60	1	②	①⑤	11.67	33.7	10.5	0.09	25.4	1.96	550.7	163.12	Y	Adenocarcinoma	②	T3N1M0
12	M	46	90	2	①	①	7.8	10.3	4.2	0.14	30.2	1.96	688.8	11.46	N	—	①	—
13	M	43	90	2	⑤	①③	12.85	29.1	13	0.12	36.1	2.26	2058.6	59.61	Y	Blood clot and a few broken glandular epithelia	②	T2N1M0
14	F	59	60	3	③	①	9.55	17.6	10.4	0.11	33.2	2.02	468.1	17.62	N	—	①	—
15	M	45	120	4	⑤	③⑥	11.57	36.2	20.6	0.16	37.7	1.98	422.6	35.24	Y	Adenocarcinoma of duodenum	③	T3N0M0

Notes a: gender (male/female); b: age (years); c: course of disease (days); d: frequency of hospitalization; e: predisposing factors (① alcohol misuse, ② gallstones, ③ hyperlipidemia, ④ overeating, and ⑤ none); f: clinical manifestation (① abdominal pain, ② obstruction of upper alimentary tract, ③ weight loss, ④ dehydration, ⑤ abdominal bloating, ⑥ nausea and vomiting, ⑦ radiating pain (back or other), and ⑧ other); g: white blood cells (WBC, ×109); h: total bilirubin (TBIL, μmol/L); i: direct bilirubin (DBIL, μmol/L); j: prealbumin (PA, g/L); k: albumin (ALB, g/L); l: calcium serum (Ca, mmol/L); m: serum amylase (AMY, IU/L); n: carbohydrate antigen (CA19-9, U/mL); o: endoscopic ultrasonography (EUS, YES/NO); p: endoscopic ultrasonography–fine-needle aspiration (EUS-FNA)/endoscopic biopsy; q: postoperative pathology (① IPMN, ② pancreatic ductal adenocarcinoma, ③ adenocarcinoma of duodenum, ④ adenoma of duodenum, and ⑤ pancreatic cystadenocarcinoma); r: pathological stage (TNM).